Monitoring versus interim analysis of clinical trials: A perspective from the pharmaceutical industry
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 10 (1) , 57-70
- https://doi.org/10.1016/0197-2456(89)90018-4
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Issues in designing sequential stopping rules for monitoring side effects in clinical trialsControlled Clinical Trials, 1987
- A clinical trial with an interim analysisStatistics in Medicine, 1986
- Early decision in clinical trials when the treatment differences are smallControlled Clinical Trials, 1985
- An Introduction to Empirical Bayes Data AnalysisThe American Statistician, 1985
- Repeated confidence intervals for group sequential clinical trialsControlled Clinical Trials, 1984
- An aid to data monitoring in long-term clinical trialsControlled Clinical Trials, 1982
- A case report of data monitoring experience: The nocturnal oxygen therapy trialControlled Clinical Trials, 1982
- On choosing the number of interim analyses in clinical trialsStatistics in Medicine, 1982
- Repeated Significance Tests on Accumulating DataJournal of the Royal Statistical Society. Series A (General), 1969
- Sequential Tests in Industrial StatisticsJournal of the Royal Statistical Society Series B: Statistical Methodology, 1946